Outcomes of human umbilical cord blood-derived mesenchymal stem cells in enhancing tendon-graft healing in anterior cruciate ligament reconstruction: an exploratory study
2
조회
0
다운로드
0
인용
0
참고문헌
초록
The study investigated whether allogeneic human umbilical cord blood-derived MSCs (hUCB-MSCs) could be safely used without treatment-related adverse events, reducing tunnel enlargement, and improve clinical results in human anterior cruciate ligament (ACL) reconstruction.Thirty patients were enrolled consecutively. They were divided into three groups by randomization. In the negative control group, ACL reconstruction surgery without additional treatment was performed. In the experimental group, a hUCB-MSC and hyaluronic acid mixture was applied to the tendon-bone interface of the femoral tunnels during ACL reconstruction surgery. In the positive control group, only hyaluronic acid was applied. Finally, 27 patients were analyzed after the exclusion of three patients. The incidence of treatment-related adverse events, clinical outcomes, including second-look arthroscopic findings, and the amount of tunnel enlargement, were evaluated. There were no treatment-related adverse events in the treatment groups. Tunnel enlargement in the experimental group (579.74 ± 389.85 mm 3 ) was not significantly different from those in the negative (641.97 ± 455.84 mm 3 ) and positive control (421.96 ± 274.83 mm 3 ) groups ( p = 0.6468). There were no significant differences between the groups in clinical outcomes such as KT-2000 measurement ( p = 0.793), pivot shift test ( p = 0.9245), International Knee Documentation Committee subjective score ( p = 0.9195), Tegner activity level ( p = 0.9927), and second-look arthroscopic findings (synovial coverage of the graft, p = 0.7984; condition of the graft, p = 0.8402). Allogeneic hUCB-MSCs were used safely for ACL reconstruction without treatment-related adverse event in a 2-year follow-up. However, our study did not suggest any evidence to show clinical advantage such as the prevention of tunnel enlargement postoperatively and a decrease in knee laxity or improvement of clinical outcomes. CRIS, Registration Number: KCT0000917. Registered on 12 November 2013; https://cris.nih.go.kr/cris/index.jsp
Abstract
The study investigated whether allogeneic human umbilical cord blood-derived MSCs (hUCB-MSCs) could be safely used without treatment-related adverse events, reducing tunnel enlargement, and improve clinical results in human anterior cruciate ligament (ACL) reconstruction.Thirty patients were enrolled consecutively. They were divided into three groups by randomization. In the negative control group, ACL reconstruction surgery without additional treatment was performed. In the experimental group, a hUCB-MSC and hyaluronic acid mixture was applied to the tendon-bone interface of the femoral tunnels during ACL reconstruction surgery. In the positive control group, only hyaluronic acid was applied. Finally, 27 patients were analyzed after the exclusion of three patients. The incidence of treatment-related adverse events, clinical outcomes, including second-look arthroscopic findings, and the amount of tunnel enlargement, were evaluated. There were no treatment-related adverse events in the treatment groups. Tunnel enlargement in the experimental group (579.74 ± 389.85 mm 3 ) was not significantly different from those in the negative (641.97 ± 455.84 mm 3 ) and positive control (421.96 ± 274.83 mm 3 ) groups ( p = 0.6468). There were no significant differences between the groups in clinical outcomes such as KT-2000 measurement ( p = 0.793), pivot shift test ( p = 0.9245), International Knee Documentation Committee subjective score ( p = 0.9195), Tegner activity level ( p = 0.9927), and second-look arthroscopic findings (synovial coverage of the graft, p = 0.7984; condition of the graft, p = 0.8402). Allogeneic hUCB-MSCs were used safely for ACL reconstruction without treatment-related adverse event in a 2-year follow-up. However, our study did not suggest any evidence to show clinical advantage such as the prevention of tunnel enlargement postoperatively and a decrease in knee laxity or improvement of clinical outcomes. CRIS, Registration Number: KCT0000917. Registered on 12 November 2013; https://cris.nih.go.kr/cris/index.jsp
참고문헌 (30)
- Sasaki K, "Enhancement of tendon-bone osteointegration of anterior cruciate ligament graft using granulocyte colony-stimulating factor", Am J Sports Med, 36(8), pp.1519~1527 (2008)[DOI]
- Silva A, "Is there a role for adult noncultivated bone marrow stem cells in ACL reconstruction?", Knee Surg Sports Traumatol Arthrosc, 22(1), pp.66~71 (2014)[DOI]
- Rizzello G, "Growth factors and stem cells for the management of anterior cruciate ligament tears", Open Orthop J, 6, pp.525~530 (2012)[DOI]
- Huangfu X, "Tendon-bone healing enhancement using injectable tricalcium phosphate in a dog anterior cruciate ligament reconstruction model", Arthroscopy, 23(5), pp.455~462 (2007)[DOI]
- Soon MY, "An analysis of soft tissue allograft anterior cruciate ligament reconstruction in a rabbit model : a short-term study of the use of mesenchymal stem cells to enhance tendon osteointegration", Am J Sports Med, 35(6), pp.962~971 (2007)[DOI]
- Yamazaki S, "The effect of transforming growth factor-beta1 on intraosseous healing of flexor tendon autograft replacement of anterior cruciate ligament in dogs", Arthroscopy, 21(9), pp.1034~1041 (2005)[DOI]
- Mutsuzaki H, "Calcium-phosphate-hybridized tendon directly promotes regeneration of tendon-bone insertion", J Biomed Mater Res A, 70(2), pp.319~327 (2004)[DOI]
- Karaoglu S, "The effects of bone marrow or periosteum on tendon-to-bone tunnel healing in a rabbit model", Knee Surg Sports Traumatol Arthrosc, 17(2), pp.170~178 (2009)[DOI]
- Ju YJ, "Synovial mesenchymal stem cells accelerate early remodeling of tendon-bone healing", Cell Tissue Res, 332(3), pp.469~478 (2008)[DOI]
- Gulotta LV, "Augmentation of tendon-to-bone healing with a magnesium-based bone adhesive", Am J Sports Med, 36(7), pp.1290~1297 (2008)[DOI]
- Hashimoto Y, "Generation of tendonto-bone interface"enthesis"with use of recombinant BMP-2 in a rabbit model", J Orthop Res, 25(11), pp.1415~1424 (2007)[DOI]
- Yu Y, "Bone morphogenetic proteins and Smad expression in ovine tendon-bone healing", Arthroscopy, 23(2), pp.205~210 (2007)[DOI]
- Li F, "ACL reconstruction in a rabbit model using irradiated Achilles allograft seeded with mesenchymal stem cells or PDGF-B genetransfected mesenchymal stem cells", Knee Surg Sports Traumatol Arthrosc, 15(10), pp.1219~1227 (2007)[DOI]
- Patrick Prager, "Mesenchymal Stem Cells Isolated from the Anterior Cruciate Ligament: Characterization and Comparison of Cells from Young and Old Donors", Knee Surgery and Related Research, 30(3), pp.193~205 (2018), 대한슬관절학회
- Lim JK, "Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction", Arthroscopy, 20(9), pp.899~910 (2004)[DOI]
- Park YB, "Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord bloodderived mesenchymal stem cells and hyaluronate hydrogel : results from a clinical trial for safety and proof-of-concept with 7 years of extended followup", Stem Cells Transl Med, 6(2), pp.613~621 (2016)[DOI]
- Jeong SY, "Thrombospondin-2secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation", Stem Cells, 31(10), pp.2136~2148 (2013)[DOI]
- Bieback K, "Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood", Stem Cells, 22(4), pp.625~634 (2004)[DOI]
- Wang M, "The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro", Immunology, 126(2), pp.220~232 (2009)[DOI]
- Jang KM, "Efficacy and safety of human umbilical cord blood-derived mesenchymal stem cells in anterior cruciate ligament reconstruction of a rabbit model: new strategy to enhance tendon graft healing", Arthroscopy, 31(8), pp.1530~1539 (2015)[DOI]
- Yang SE, "Mesenchymal stem", progenitor cells developed in cultures from UC blood, 2004, pp.6(5), 476~486
- Fu FH, "The lateral intercondylar ridge—a key to anatomic anterior cruciate ligament reconstruction", J Bone Joint Surg Am, 89(10), pp.2103~2104 (2007)
- Kim JG, "Femoral graft bending angle and femoral tunnel geometry of transportal and outside-in techniques in anterior cruciate ligament reconstruction: an in vivo 3-dimensional computed tomography analysis", Arthroscopy, 28(11), pp.1682~1694 (2012)[DOI]
- Yasuda K, "Anatomic reconstruction of the anteromedial and posterolateral bundles of the anterior cruciate ligament using hamstring tendon grafts", Arthroscopy, 20(10), pp.1015~1025 (2004)[DOI]
- Trotti A, "CTCAE v3. 0 : development of a comprehensive grading system for the adverse effects of cancer treatment", Semin Radiat Oncol, 13(3), pp.176~181 (2003)[DOI]
- Kinugasa K, "Effect of patient age on morphology of anterior cruciate ligament grafts at second-look arthroscopy", Arthroscopy, 27(1), pp.38~45 (2011)[DOI]
- Tanaka Y, "Triple-bundle ACL grafts evaluated by second-look arthroscopy", Knee Surg Sports Traumatol Arthrosc, 20(1), pp.95~101 (2012)[DOI]
- Salmon L, "Incidence and risk factors for graft rupture and contralateral rupture after anterior cruciate ligament reconstruction", Arthroscopy, 21(8), pp.948~957 (2005)[DOI]
- Edwards SL, "Biologic and pharmacologic augmentation of rotator cuff repairs", J Am Acad Orthop Surg, 19(10), pp.583~589 (2011)[DOI]
- Yagishita K, "The effect of hyaluronan on tendon healing in rabbits", Arthroscopy, 21(11), pp.1330~1336 (2005)[DOI]